C. Bethan Powell, MD
Obstetrics and Gynecology • Cancer GeneticsMedical Director, Cancer Genetics and Prevention
C. Bethan Powell, MD
Obstetrics and Gynecology • Cancer GeneticsMedical Director, Cancer Genetics and PreventionOn this page
Education & training
Board certification
- Gynecologic Oncology, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Gynecology, Washington University School of Medicine
Residency
- Pennsylvania Hospital OB/GYN Residency Program
Internship
- Pennsylvania Hospital
Degree
- MD, University of Pennsylvania
My expertise
Specialties
Conditions
- Hereditary Cancer Risk
Treatments
- Cancer Prevention
- Breast Cancer Prevention and Risk Reduction
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%225794%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225794%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.